About Index Trending news
Analyze
Pricing
DBV Technologies

DBV Technologies

Work at DBV Technologies? Add yourself to this profile

DBV Technologies

DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.

Elsewhere

Contributors to this profile

Alexa global traffic share

21 Jul 2015
$281,500,000
Post-IPO equity
Added by

DBV Technologies Closes $281.5M Public Offering | FinSMEs

FinSMEs
05 Jan 2011
$25,500,000
Venture capital (Series C)
Sofinnova Partners, Alto Invest, ALK Abelló, +2
Added by

DBV Technologies Raises $25.5M Series C For Peanut Allergy Patch

dowjones
17 Dec 2010
$2,700,000
Venture capital
Added by

DBV Raises Additional $2.7M To Develop Peanut Allergy Vaccine

dowjones